Atlas Trials

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Clinical trial NCT06483048 · RECRUITING

Trial details

NCT number
NCT06483048
Sponsor
Mayo Clinic
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Fallopian Tube CarcinosarcomaRecurrent Female Reproductive System CarcinomaRecurrent Ovarian CarcinomaRecurrent Ovarian CarcinosarcomaRecurrent Platinum-Resistant Fallopian Tube CarcinomaRecurrent Platinum-Resistant Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaRecurrent Primary Peritoneal Carcinosarcoma
Start date
2024-09-20
Primary completion
2028-09-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.